<DOC>
	<DOC>NCT02290821</DOC>
	<brief_summary>This study will assess the analgesic efficacy of DSG 1% compared to placebo in the reduction of the pain associated with acute blunt trauma injuries.</brief_summary>
	<brief_title>Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Contusions</mesh_term>
	<mesh_term>Soft Tissue Injuries</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Male or female subjects aged 16 years and over Fresh impact injury of the upper or lower limbs, not requiring admittance to hospital &amp; meeting baseline pain intensity level Anticipated time between injury and treatment must be â‰¤ 6 hours Pain medication prior to randomization Topical analgesic or antiinflammatory treatment over the previous month in the area to be treated Any physical impairment that would influence efficacy assessments, such as peripheral or central neurological disease, significant back pain, painful conditions of the upper or lower extremities Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>